Solvay (SOLB) Posts Preliminary Q3 Results; Updates 2026 Guidance

Solvay (SOLB) reported preliminary Q3 2026 net sales of €1.03B, underlying EBITDA of €173M, and FCF to shareholders of €54M. The company updated FY26 guidance, citing a €25M EBITDA impact from Middle East conflict. Solvay continues to focus on cash and cost management.

Original reporting
Published Oct 19, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 4:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Solvay (SOLB) Posts Preliminary Q3 Results; Updates 2026 Guidance — source image
Decision brief

The 30-second read

Med
01

Why it matters

Preliminary results signal a material earnings hit, prompting a reassessment of FY26 guidance.

02

Market read

The earnings update provides fresh guidance and conflict‑related earnings impact, relevant for traders with exposure to European chemicals stocks.

03

What to watch

Potential upside from any resolution at Sadara or recovery payments not yet quantified.

Relevance 7/10Novelty 7/10Timing: after‑hours release

Background

Solvay is a global chemicals and materials company; the Middle East conflict has disrupted operations in the region.

Market effects

Chemicals sector may see broader pressure from Middle East conflict exposure.

European markets could react to Solvay's guidance downgrade.

Limited to investors with exposure to Solvay or the chemicals industry.

Counterpoint

If the conflict impact is short‑lived, the stock could rebound on cost‑cutting measures.

Key entities

  • Solvay

    Global chemicals and materials group reporting Q3 2026 preliminary results.

Related articles

Med

Why is Solvay stock sliding today?

Solvay (SOLB) stock fell 4.2% to €23.86 after reporting Q3 2026 EBITDA of €173M, below consensus. The company cut full-year EBITDA guidance to €720-740M and free cash flow to €120-150M. Analysts reduced price targets, citing geopolitical disruptions and earnings concerns. The stock hit a 52-week low of €22.58.

MedAI 8/10

Solvay S.A.: Solvay second quarter 2026 results

Solvay reported Q2 2026 results. Underlying net sales were €1,031 million, down 7.4% organically, and underlying EBITDA was €187 million (18.1% margin), down 19.5% organically, citing weak soda ash pricing and Middle East disruption. Underlying net profit from continuing operations was €64 million. Full-year 2026 guidance was confirmed: EBITDA €770–€850 million and free cash flow at least €200 million. Solvay approved €15–20 million rare-earth capacity investments at La Rochelle.

$NEEHighAI 8/10

NextEra Energy reports third-quarter 2026 financial results

NEXTERA ENERGY INC (NEE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99 NextEra Energy, Inc. Media Line: 561-694-4442 Oct. 21, 2026 FOR IMMEDIATE RELEASE NextEra Energy reports third-quarter 2026 financial results • NextEra Energy delivers strong third-quarter results • FPL grows regulatory capital employed by approximately 9.2% year-over-

$ONBMed

Old National Bancorp Q3 Profit Rises

Old National Bancorp reported Q3 net income of $249.96M, or $0.66 per share, up from $178.53M, or $0.46 per share, a year earlier. Revenue rose to $720.4M, while provision for credit losses increased to $33.58M. Shares were down 1% in pre-market trading.